Sage Therapeutics, Inc. — Form D
Sage Therapeutics, Inc. of CAMBRIDGE, MA, a company, filed a Form D exempt-offering notice with the SEC on 2021-01-15. The offering totals $650.0M, of which $650.0M was reported sold. Industry: Pharmaceuticals.
Offering
- Filed: 2021-01-15
- Form: D
- Accession: 0001597553-21-000002
- Industry: Pharmaceuticals
- Exemptions: 06b
- Total offering: $650.0M
- Amount sold: $650.0M
- Investors: 1
- Date of first sale: 2020-12-31
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-386553
Issuer
- Name: Sage Therapeutics, Inc.
- CIK: 0001597553
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2010
- Address: 215 FIRST STREET, CAMBRIDGE, MA, 02142
- Phone: 617-299-8380
Officers, directors & promoters (22)
| Name | Role | Location |
|---|
| Elizabeth F Barrett | Director | Cambridge, MA |
| Michael F Cola | Director | Cambridge, MA |
| James F Frates | Director | Cambridge, MA |
| Geno F Germano | Director | Cambridge, MA |
| George F Golumbeski | Director | Cambridge, MA |
| Barry Greene | Director | Grand Falls-Windsor, A4 |
| Jeffrey M Jonas | Director | Cambridge, MA |
| Steven F Paul | Director | Cambridge, MA |
| Kevin P Starr | Director | Cambridge, MA |
| Michael Cloonan | Executive Officer | Cambridge, MA |
| Anne Marie Cook | Executive Officer | Cambridge, MA |
| Barry Greene | Executive Officer | Grand Falls-Windsor, A4 |
| Kimi Iguchi | Executive Officer | Cambridge, MA |
| Jeffrey M Jonas | Executive Officer | Cambridge, MA |
| Stephen J Kanes | Executive Officer | Cambridge, MA |
| Albert J Robichaud | Executive Officer | Cambridge, MA |
| Robert T Nelsen | Director | Chicago, IL |
| Steven T Paul | Director | Cambridge, MA |
| Kevin T Starr | Director | Cambridge, MA |
| Jeffery M Jonas | Director | Cambridge, MA |
| Jeffery M Jonas | Executive Officer | Cambridge, MA |
| Kimi M Iguchi | Executive Officer | Cambridge, MA |
Other filings by this issuer (2)
More